[Mycobacterium marinum infection after aquarium exposure: Review of published cases and clinical experience]

Related Experiment Video

Updated: Jul 14, 2026

Environmental Screening of Aeromonas hydrophila, Mycobacterium spp., and Pseudocapillaria tomentosa in Zebrafish Systems
09:58

Environmental Screening of Aeromonas hydrophila, Mycobacterium spp., and Pseudocapillaria tomentosa in Zebrafish Systems

Published on: December 8, 2017

10.2K

C Llamas-Segura1, M D Pegalajar-García1, I Pérez-López1

  • 1Servicio de Dermatología Médico-Quirúrgica y Venereología, Hospital Clínico Universitario San Cecilio, Granada, España.

Semergen
|November 6, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Modeling Tuberculosis in Mycobacterium marinum Infected Adult Zebrafish
07:00

Modeling Tuberculosis in Mycobacterium marinum Infected Adult Zebrafish

Published on: October 8, 2018

11.2K
Visualization of Macrophage Lytic Cell Death During Mycobacterial Infection in Zebrafish Embryos via Intravital Microscopy
06:49

Visualization of Macrophage Lytic Cell Death During Mycobacterial Infection in Zebrafish Embryos via Intravital Microscopy

Published on: January 9, 2019

6.8K

Related Experiment Videos

Last Updated: Jul 14, 2026

Environmental Screening of Aeromonas hydrophila, Mycobacterium spp., and Pseudocapillaria tomentosa in Zebrafish Systems
09:58

Environmental Screening of Aeromonas hydrophila, Mycobacterium spp., and Pseudocapillaria tomentosa in Zebrafish Systems

Published on: December 8, 2017

10.2K
Modeling Tuberculosis in Mycobacterium marinum Infected Adult Zebrafish
07:00

Modeling Tuberculosis in Mycobacterium marinum Infected Adult Zebrafish

Published on: October 8, 2018

11.2K
Visualization of Macrophage Lytic Cell Death During Mycobacterial Infection in Zebrafish Embryos via Intravital Microscopy
06:49

Visualization of Macrophage Lytic Cell Death During Mycobacterial Infection in Zebrafish Embryos via Intravital Microscopy

Published on: January 9, 2019

6.8K

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

Articles linked to this work by shared authors, journal, and citation graph.

Adverse events associated with topical corticosteroid use in moderate-to-severe atopic dermatitis: a prospective analysis from the BIOBADATOP registry.

Actas dermo-sifiliograficas·2026

Analysis of the Influence of Sex in 507 Patients With Moderate-to-Severe Atopic Dermatitis: Spanish Atopic Dermatitis Registry (BIOBADATOP).

Actas dermo-sifiliograficas·2026

Health Care Resource Utilization in Patients With Atopic Dermatitis According to Treatment Response: Evidence From the BIOBADATOP Registry.

Actas dermo-sifiliograficas·2026

Multidisciplinary Delphi Consensus Between Primary Care and Dermatology on Updated Management of Actinic Keratosis in Spain.

Actas dermo-sifiliograficas·2025

[Evaluation of the efficacy and concordance between primary and specialized care in the treatment of actinic keratosis using daylight photodynamic therapy monitored by teledermatology].

Semergen·2025

Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical Practice.

Actas dermo-sifiliograficas·2025

[Mild traumatic brain injury in prehospital primary care emergency services: care pathway and the opportunity of point-of-care biomarkers].

Semergen·2026

[Coordination between Primary Care and the Primary Care Clinical Psychology Program (PSICAP) for the Detection and Management of Suicidal Behavior: Recommendations for Good Clinical Practice].

Semergen·2026

[Healthcare expenditure and in-hospital mortality in the Spanish National Health System (2013-2023)].

Semergen·2026

[Delabeling of self-reported penicillin allergy in Primary Care: patient selection and oral challenge test].

Semergen·2026

[Diabetic Foot Status (DFS): A IWGDF-based classification for the assessment and management of diabetic foot disease in primary care].

Semergen·2026

[Early recognition of fibrosing interstitial lung disease: practical recommendations for initial evaluation and referral].

Semergen·2026

[Measurable residual disease in acute myeloid leukemia: clinical significance and emerging roles in personalized therapy].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

The natural history of Mycobacterium abscessus in Cystic Fibrosis and the impact of Elexacaftor/tezacaftor/ivacaftor.

Respiratory medicine·2026

Site-Specific Treatment and Remission Patterns in Multisite Mucous Membrane Pemphigoid.

JAMA dermatology·2026

Anti-Helicobacter pylori Activity of Musa 'False Horn' (Musaceae), Syzygium aromaticum (Myrtaceae), Psidium guajava (Myrtaceae), Mangifera indica (Anacardiaceae), and Cymbopogon citratus (Poaceae) and Their Potential to Prevent and Eradicate H. pylori Biofilms.

BioMed research international·2026

MPT64 secretion as a viability-associated immunoassay readout for rapid phenotypic drug susceptibility classification of Mycobacterium tuberculosis: a proof-of-concept study.

The Journal of antimicrobial chemotherapy·2026

Comparison of the performance of clinical classification systems for myasthenia gravis relapse after thymoma resection.

JTCVS open·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us